Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine

NCT00258700 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b
Neisseria Meningitidis

Interventions

BIOLOGICAL: Haemophilus influenzae type b- and meningococcal (vaccine)

Sponsor

GlaxoSmithKline